Arteritis: Clinical Trials

17 trials for Arteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting, 5 unknown, 3 not yet recruiting, 2 completed. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Recruiting 6, Unknown 5, Not yet recruiting 3, Completed 2, Enrolling by invitation 1

Follow Arteritis: new trials by email Literature Review of Arteritis trials Research Report on Arteritis

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
Vanakizumab, Ivarmacitinib, Prednisone - Takayasu Arteritis (TAK)
Phase 4Not yet recruitingChinese SLE Treatment And Research Group1802026-04-012026-03-05
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA)
Phase 4RecruitingUniversity of Sao Paulo General Hospital4772026-03-162026-07-20
Effect of Pirfenidone on TA Fibrosis
Pirfenidone Capsules, Placebo - Takayasu Arteritis
Phase 4Not yet recruitingShanghai Zhongshan Hospital922025-12-202026-01-08
The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis
Deucravacitinib, Adalimumab - Takayasu Arteritis (TAK)
Phase 4Not yet recruitingChinese SLE Treatment And Research Group502025-06-152025-06-10
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
Shingrix, vaccination with 2 doses of Shingrix vaccine - Systemic Vasculitis, Spondylarthropathies
Phase 4Enrolling by invitationRegion Skane2402024-12-172025-01-10
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
Prednisone, Methotrexate, Tocilizumab - Takayasu Arteritis
Phase 4RecruitingShanghai Zhongshan Hospital1242024-06-282024-10-17
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
Hydrocortisone, Placebo for hydrocortisone - Adrenal Insufficiency, Polymyalgia Rheumatica
Phase 4RecruitingMarianne Christina Klose2502022-06-072026-03-16
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment
Hydrocortisone, Placebo - Adrenal Insufficiency, Polymyalgia Rheumatica (PMR)
Phase 4RecruitingMarianne Andersen1002022-02-012025-12-22
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Adalimumab Injection, Tofacitinib 5 MG - Takayasu Arteritis
Phase 4UnknownChinese SLE Treatment And Research Group1002022-01-052023-07-24
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
Tofacitinib, Methotrexate - Takayasu Arteritis
Phase 4RecruitingShanghai Zhongshan Hospital762021-11-012024-10-15
A Pilot Study in Severe Patients With Takayasu Arteritis.
Tocilizumab, Adalimumab - Takayasu Arteritis, Tocilizumab
Phase 4RecruitingShanghai Zhongshan Hospital402020-03-012021-08-10
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
Methotrexate Tablets, Tofacitinib tablet - Takayasu Arteritis, Methotrexate
Phase 4UnknownShanghai Zhongshan Hospital1302020-03-012020-06-12
Tocilizumab Plus a Short Prednisone Taper for GCA
Tocilizumab, Prednisone - Giant Cell Arteritis
Phase 4CompletedMassachusetts General Hospital302018-11-282022-12-02
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
Tocilizumab - Giant Cell Arteritis
Phase 4UnknownHospital of Prato152015-01-012017-08-10
Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
Prednisone therapy and pharmacokinetic - Giant Cell Arteritis
Phase 4UnknownUniversity Hospital, Caen1502009-07-012014-04-09
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
prednisone, methylprednisolone,cyclophosphamides, Cyclophosphamide, Azathioprine,prednisone,methylprednisolone, Mycophenolate mofetil,methotrexate - Vasculitis, Wegener's Granulomatosis
Phase 4CompletedAssistance Publique - Hôpitaux de Paris1082005-07-012011-09-12
CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
azathioprine, cyclophosphamide - Polyarteritis Nodosa, Microscopic Polyangiitis
Phase 4UnknownHospices Civils de Lyon1241996-07-012006-11-16

Narrower conditions

Takayasu Arteritis (9)  ·  Giant Cell Arteritis (6)  ·  Microscopic Polyangiitis (3)  ·  Polymyalgia Rheumatica (3)  ·  Adrenal Insufficiency (2)  ·  Arthritis, Juvenile (2)  ·  Arthritis, Psoriatic (2)  ·  Granulomatosis with Polyangiitis (2)  ·  Polyarteritis Nodosa (2)  ·  Vasculitis (2)  ·  Antiphospholipid Syndrome (1)  ·  Aortitis (1)  ·  Arthritis (1)  ·  Arthritis, Rheumatoid (1)  ·  Axial Spondyloarthritis (1)

Broader conditions

Cardiovascular Diseases (17)  ·  Skin Diseases (17)  ·  Skin Diseases, Vascular (17)  ·  Skin and Connective Tissue Diseases (17)  ·  Vascular Diseases (17)  ·  Vasculitis (15)  ·  Aortic Diseases (10)  ·  Aortic Arch Syndromes (9)  ·  Autoimmune Diseases (9)  ·  Brain Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Cerebrovascular Disorders (9)  ·  Immune System Diseases (9)  ·  Nervous System Diseases (9)

Interventions

Adalimumab (4)  ·  Methotrexate (4)  ·  Prednisone (4)  ·  tocilizumab (4)  ·  tofacitinib (4)  ·  Azathioprine (2)  ·  Cyclophosphamide (2)  ·  Glucocorticoids (2)  ·  Hydrocortisone (2)  ·  Methylprednisolone (1)  ·  Mycophenolic Acid (1)  ·  Vaccination (1)  ·  Vaccines (1)  ·  deucravacitinib (1)  ·  ivarmacitinib (1)

Sponsors

Shanghai Zhongshan Hospital (5)  ·  Chinese SLE Treatment And Research Group (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital of Prato (1)  ·  Marianne Andersen (1)  ·  Marianne Christina Klose (1)  ·  Massachusetts General Hospital (1)  ·  Region Skane (1)  ·  University Hospital, Caen (1)  ·  University of Sao Paulo General Hospital (1)

Countries

China (7)  ·  Denmark (2)  ·  France (2)  ·  Brazil (1)  ·  Italy (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Lindi Jiang, PhD (3)  ·  Ana D Fernandes, MA (1)  ·  Lindi Jiang, Ph.D., M.D. (1)  ·  Marianne Klose, MD, PhD (1)  ·  Marianne S Andersen (1)  ·  Ulla Feldt-Rasmussen, Professor (1)  ·  Xiaofeng Zeng, MD (1)  ·  Xinping Tian, MD (1)

Results publications

PMID 14558057, PMID 22674883, PMID 25153486, PMID 25693055, PMID 25697557, PMID 37540159, PMID 38251564, PMID 41638742, PMID 42276802

NIH funding

2008 (1), 2023 (1)